Scanning laser polarimetry with variable corneal compensation and detection of glaucomatous optic neuropathy

The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes. Sixty-five healthy and 59 glaucomatous age-matched patients underwent...

Full description

Saved in:
Bibliographic Details
Published inGraefe's archive for clinical and experimental ophthalmology Vol. 243; no. 8; pp. 774 - 779
Main Authors Da Pozzo, Stefano, Iacono, Pierluigi, Marchesan, Roberta, Fantin, Anna, Ravalico, Giuseppe
Format Journal Article
LanguageEnglish
Published Germany Springer Nature B.V 01.08.2005
Subjects
Online AccessGet full text
ISSN0721-832X
1435-702X
DOI10.1007/s00417-004-1118-1

Cover

Loading…
Abstract The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes. Sixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values. All SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability. SLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40.
AbstractList The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes. Sixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values. All SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability. SLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40.
The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes. Sixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values. All SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability. SLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40.
The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes.BACKGROUNDThe aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes.Sixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values.METHODSSixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values.All SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability.RESULTSAll SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability.SLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40.CONCLUSIONSSLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40.
Author Da Pozzo, Stefano
Ravalico, Giuseppe
Iacono, Pierluigi
Fantin, Anna
Marchesan, Roberta
Author_xml – sequence: 1
  givenname: Stefano
  surname: Da Pozzo
  fullname: Da Pozzo, Stefano
– sequence: 2
  givenname: Pierluigi
  surname: Iacono
  fullname: Iacono, Pierluigi
– sequence: 3
  givenname: Roberta
  surname: Marchesan
  fullname: Marchesan, Roberta
– sequence: 4
  givenname: Anna
  surname: Fantin
  fullname: Fantin, Anna
– sequence: 5
  givenname: Giuseppe
  surname: Ravalico
  fullname: Ravalico, Giuseppe
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15756574$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFrFTEQxoNU7GvrH-BFggdvq5lkd7N7lNKqUPCghd7CvOyk3ZKXrElWef-9aV9F6MHLDMP8vmH4vhN2FGIgxt6A-ABC6I9ZiBZ0U2sDAEMDL9gGWtU1WsibI7YRWkIzKHlzzE5yvhcVVB28YsfQ6a7vdLth_rvFEOZwyz1mSnyJHtO8o5L2_Pdc7vivOuLWE7cxBUJf-26hkLHMMXAME5-okH2couO3HtdKYIlr5nEps-WB1hQXLHf7M_bSoc_0-qmfsuvLix_nX5qrb5-_nn-6aqySfWmc6yfV9wpcZ5XejlI7IOX6QZCjaetQEnYTCTGquu6s0ORGN4KU0INCVKfs_eHukuLPlXIxuzlb8h4D1b9MP3SqHduhgu-egfdxTaH-ZqQSehxkqyv09glatzuazFL9wbQ3f02sABwAm2LOidw_RJiHoMwhKFOreQjKQNXoZxo7l0dPS8LZ_0f5ByM5mVQ
CitedBy_id crossref_primary_10_1038_eye_2008_50
crossref_primary_10_1097_IJG_0b013e3180316754
crossref_primary_10_1111_j_1755_3768_2011_02133_x
crossref_primary_10_1016_j_jaapos_2008_03_011
crossref_primary_10_1136_bjo_2008_145540
crossref_primary_10_1007_s10384_009_0717_0
crossref_primary_10_1016_j_survophthal_2013_04_007
crossref_primary_10_1097_IJG_0b013e318168f01a
crossref_primary_10_1097_OPX_0b013e31824f164d
crossref_primary_10_1007_s10384_010_0870_5
crossref_primary_10_1186_1471_2202_9_93
crossref_primary_10_1016_j_optm_2008_12_011
crossref_primary_10_1038_eye_2015_158
crossref_primary_10_1111_j_1442_9071_2008_01891_x
crossref_primary_10_1002_14651858_CD008803_pub2
Cites_doi 10.1001/archopht.1980.01020030486010
10.1016/S0002-9394(02)01512-X
10.1016/S0002-9394(00)00353-6
10.1016/S0161-6420(02)01899-7
10.1016/j.ophtha.2004.04.024
10.1167/iovs.03-0692
10.1001/archopht.119.7.985
10.1001/jama.1994.03510330081039
10.1167/iovs.02-0814
10.1001/archopht.1982.01030030137016
10.1016/S0002-9394(14)70993-6
10.1016/S0002-9394(02)02077-9
10.1016/S0002-9394(14)72726-6
10.1097/00061198-200008000-00001
10.1001/archopht.1991.01080010079037
10.1001/archopht.121.7.961
10.1001/archopht.120.7.901
10.1016/0895-4356(91)90128-V
10.3928/1542-8877-20020301-08
10.1167/iovs.03-0646
10.1016/j.ophtha.2003.05.015
10.1001/archopht.120.6.701
10.1001/archopht.122.6.827
10.1067/mem.2003.273
10.1016/S0161-6420(03)00479-2
10.1001/archopht.1990.01070060105058
ContentType Journal Article
Copyright Springer-Verlag 2005
Copyright_xml – notice: Springer-Verlag 2005
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1007/s00417-004-1118-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Academic Middle East (New)
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1435-702X
EndPage 779
ExternalDocumentID 982194621
15756574
10_1007_s00417_004_1118_1
Genre Journal Article
GroupedDBID ---
-Y2
.55
.86
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
28-
29I
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
4.4
406
408
409
40D
40E
53G
5QI
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYXX
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSTC
ACUDM
ACZOJ
ADBBV
ADHIR
ADHKG
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ATHPR
AXYYD
AYFIA
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
CITATION
COF
CSCUP
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PF0
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
X7M
YLTOR
Z45
ZMTXR
ZOVNA
~EX
-53
-5E
-5G
-BR
-EM
-~C
3V.
AAAVM
ADINQ
CGR
CUY
CVF
ECM
EIF
GQ6
NPM
Z7U
Z81
Z82
Z83
Z87
Z8O
Z8U
Z8V
Z8W
Z91
7TK
7XB
8FK
ABRTQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c326t-ff6d36631f5c37b927f1e3f680efedbfa2ea5de009337b5c07ef9f91221613aa3
IEDL.DBID 7X7
ISSN 0721-832X
IngestDate Thu Aug 07 14:25:15 EDT 2025
Thu Aug 14 17:30:59 EDT 2025
Wed Feb 19 01:39:00 EST 2025
Tue Jul 01 02:07:45 EDT 2025
Thu Apr 24 22:51:30 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c326t-ff6d36631f5c37b927f1e3f680efedbfa2ea5de009337b5c07ef9f91221613aa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 15756574
PQID 230798247
PQPubID 48614
PageCount 6
ParticipantIDs proquest_miscellaneous_68534948
proquest_journals_230798247
pubmed_primary_15756574
crossref_primary_10_1007_s00417_004_1118_1
crossref_citationtrail_10_1007_s00417_004_1118_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2005-8-00
2005-Aug
20050801
PublicationDateYYYYMMDD 2005-08-01
PublicationDate_xml – month: 08
  year: 2005
  text: 2005-8-00
PublicationDecade 2000
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Heidelberg
PublicationTitle Graefe's archive for clinical and experimental ophthalmology
PublicationTitleAlternate Graefes Arch Clin Exp Ophthalmol
PublicationYear 2005
Publisher Springer Nature B.V
Publisher_xml – name: Springer Nature B.V
References RN Weinreb (1118_CR30) 2002; 120
EJ Gallagher (1118_CR6) 2003; 42
D Tannenbaum (1118_CR25) 2004; 111
C Bowd (1118_CR2) 2001; 42
C Bowd (1118_CR3) 2003; 121
NJ Reus (1118_CR19) 2004; 111
DS Greenfield (1118_CR8) 2002; 134
MA Kass (1118_CR11) 2002; 120
H Bagga (1118_CR1) 2003; 135
YY Chen (1118_CR4) 1998; 7
MJ Tjon-Fo-Sang (1118_CR26) 1997; 123
NJ Reus (1118_CR20) 2004; 45
JR Shields (1118_CR22) 2002; 33
DL Simel (1118_CR23) 1991; 44
JE Pederson (1118_CR16) 1980; 98
E Hodapp (1118_CR9) 1993
FA Medeiros (1118_CR15) 2004; 122
FA Medeiros (1118_CR14) 2003; 44
DS Greenfield (1118_CR7) 2000; 129
NJ Reus (1118_CR18) 2003; 110
LM Zangwill (1118_CR31) 2001; 119
RN Weinreb (1118_CR27) 1990; 108
RN Weinreb (1118_CR29) 2002; 120
NT Choplin (1118_CR5) 2003; 110
A Sommer (1118_CR24) 1991; 109
Q Zhou (1118_CR32) 2002; 43
RN Weinreb (1118_CR28) 1995; 120
YH Kwon (1118_CR13) 2000; 9
RW Knighton (1118_CR12) 2002; 43
PG Schlottmann (1118_CR21) 2004; 45
R Jaeschke (1118_CR10) 1994; 271
HA Quigley (1118_CR17) 1982; 100
12766063 - Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2606-12
12689893 - Ophthalmology. 2003 Apr;110(4):719-25
11942543 - Ophthalmic Surg Lasers. 2002 Mar-Apr;33(2):123-6
10926978 - Am J Ophthalmol. 2000 Jun;129(6):715-22
1987954 - Arch Ophthalmol. 1991 Jan;109(1):77-83
11773016 - Invest Ophthalmol Vis Sci. 2002 Jan;43(1):82-6
12049574 - Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30
12860798 - Arch Ophthalmol. 2003 Jul;121(7):961-6
8309035 - JAMA. 1994 Mar 2;271(9):703-7
12583788 - Arch Ophthalmol. 2003 Feb;121(2):218-24
11481263 - Invest Ophthalmol Vis Sci. 2001 Aug;42(9):1993-2003
15161846 - Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1823-9
12654370 - Am J Ophthalmol. 2003 Apr;135(4):521-9
7362506 - Arch Ophthalmol. 1980 Mar;98(3):490-5
15465547 - Ophthalmology. 2004 Oct;111(10):1860-5
7055464 - Arch Ophthalmol. 1982 Jan;100(1):135-46
2322159 - Arch Ophthalmol. 1990 Apr;108(4):557-60
12883522 - Ann Emerg Med. 2003 Aug;42(2):298-303
12091420 - Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2221-8
12917165 - Ophthalmology. 2003 Aug;110(8):1512-6
9786559 - J Glaucoma. 1998 Oct;7(5):312-6
15197057 - Arch Ophthalmol. 2004 Jun;122(6):827-37
10958600 - J Glaucoma. 2000 Aug;9(4):281-8
1941027 - J Clin Epidemiol. 1991;44(8):763-70
8540546 - Am J Ophthalmol. 1995 Dec;120(6):732-8
15019373 - Ophthalmology. 2004 Feb;111(2):259-64
12095804 - Am J Ophthalmol. 2002 Jul;134(1):27-33
11448320 - Arch Ophthalmol. 2001 Jul;119(7):985-93
14985299 - Invest Ophthalmol Vis Sci. 2004 Mar;45(3):840-5
9186098 - Am J Ophthalmol. 1997 Jan;123(1):62-9
12096960 - Arch Ophthalmol. 2002 Jul;120(7):901-6
References_xml – volume: 98
  start-page: 490
  year: 1980
  ident: 1118_CR16
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1980.01020030486010
– volume: 134
  start-page: 27
  year: 2002
  ident: 1118_CR8
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(02)01512-X
– volume: 129
  start-page: 715
  year: 2000
  ident: 1118_CR7
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(00)00353-6
– volume: 43
  start-page: 2221
  year: 2002
  ident: 1118_CR32
  publication-title: Invest Ophthalmol Vis Sci
– volume: 110
  start-page: 719
  year: 2003
  ident: 1118_CR5
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(02)01899-7
– volume: 7
  start-page: 312
  year: 1998
  ident: 1118_CR4
  publication-title: J Glaucoma
– volume: 111
  start-page: 1860
  year: 2004
  ident: 1118_CR19
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2004.04.024
– volume: 45
  start-page: 1823
  year: 2004
  ident: 1118_CR21
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.03-0692
– volume: 119
  start-page: 985
  year: 2001
  ident: 1118_CR31
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.119.7.985
– volume: 271
  start-page: 703
  year: 1994
  ident: 1118_CR10
  publication-title: JAMA
  doi: 10.1001/jama.1994.03510330081039
– volume: 44
  start-page: 2606
  year: 2003
  ident: 1118_CR14
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.02-0814
– volume: 100
  start-page: 135
  year: 1982
  ident: 1118_CR17
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1982.01030030137016
– volume: 123
  start-page: 62
  year: 1997
  ident: 1118_CR26
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(14)70993-6
– volume: 42
  start-page: 1993
  year: 2001
  ident: 1118_CR2
  publication-title: Invest Ophthalmol Vis Sci
– volume: 135
  start-page: 521
  year: 2003
  ident: 1118_CR1
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(02)02077-9
– volume: 120
  start-page: 732
  year: 1995
  ident: 1118_CR28
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(14)72726-6
– volume: 9
  start-page: 281
  year: 2000
  ident: 1118_CR13
  publication-title: J Glaucoma
  doi: 10.1097/00061198-200008000-00001
– volume: 109
  start-page: 77
  year: 1991
  ident: 1118_CR24
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1991.01080010079037
– volume: 121
  start-page: 961
  year: 2003
  ident: 1118_CR3
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.121.7.961
– volume: 120
  start-page: 218
  year: 2002
  ident: 1118_CR29
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.120.7.901
– volume: 44
  start-page: 763
  year: 1991
  ident: 1118_CR23
  publication-title: J Clin Epidemiol
  doi: 10.1016/0895-4356(91)90128-V
– volume: 33
  start-page: 123
  year: 2002
  ident: 1118_CR22
  publication-title: Ophthalmic Surg Lasers
  doi: 10.3928/1542-8877-20020301-08
– start-page: 52
  volume-title: Clinical decisions in glaucoma
  year: 1993
  ident: 1118_CR9
– volume: 43
  start-page: 82
  year: 2002
  ident: 1118_CR12
  publication-title: Invest Ophthalmol Vis Sci
– volume: 45
  start-page: 840
  year: 2004
  ident: 1118_CR20
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.03-0646
– volume: 111
  start-page: 259
  year: 2004
  ident: 1118_CR25
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2003.05.015
– volume: 120
  start-page: 701
  year: 2002
  ident: 1118_CR11
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.120.6.701
– volume: 122
  start-page: 827
  year: 2004
  ident: 1118_CR15
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.122.6.827
– volume: 42
  start-page: 298
  year: 2003
  ident: 1118_CR6
  publication-title: Ann Emerg Med
  doi: 10.1067/mem.2003.273
– volume: 110
  start-page: 1512
  year: 2003
  ident: 1118_CR18
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(03)00479-2
– volume: 120
  start-page: 901
  year: 2002
  ident: 1118_CR30
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.120.7.901
– volume: 108
  start-page: 557
  year: 1990
  ident: 1118_CR27
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1990.01070060105058
– reference: 11481263 - Invest Ophthalmol Vis Sci. 2001 Aug;42(9):1993-2003
– reference: 10958600 - J Glaucoma. 2000 Aug;9(4):281-8
– reference: 8540546 - Am J Ophthalmol. 1995 Dec;120(6):732-8
– reference: 7362506 - Arch Ophthalmol. 1980 Mar;98(3):490-5
– reference: 15197057 - Arch Ophthalmol. 2004 Jun;122(6):827-37
– reference: 1941027 - J Clin Epidemiol. 1991;44(8):763-70
– reference: 11942543 - Ophthalmic Surg Lasers. 2002 Mar-Apr;33(2):123-6
– reference: 12095804 - Am J Ophthalmol. 2002 Jul;134(1):27-33
– reference: 12049574 - Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30
– reference: 12766063 - Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2606-12
– reference: 15019373 - Ophthalmology. 2004 Feb;111(2):259-64
– reference: 8309035 - JAMA. 1994 Mar 2;271(9):703-7
– reference: 2322159 - Arch Ophthalmol. 1990 Apr;108(4):557-60
– reference: 1987954 - Arch Ophthalmol. 1991 Jan;109(1):77-83
– reference: 11773016 - Invest Ophthalmol Vis Sci. 2002 Jan;43(1):82-6
– reference: 12883522 - Ann Emerg Med. 2003 Aug;42(2):298-303
– reference: 12096960 - Arch Ophthalmol. 2002 Jul;120(7):901-6
– reference: 12091420 - Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2221-8
– reference: 11448320 - Arch Ophthalmol. 2001 Jul;119(7):985-93
– reference: 15465547 - Ophthalmology. 2004 Oct;111(10):1860-5
– reference: 12917165 - Ophthalmology. 2003 Aug;110(8):1512-6
– reference: 12860798 - Arch Ophthalmol. 2003 Jul;121(7):961-6
– reference: 9786559 - J Glaucoma. 1998 Oct;7(5):312-6
– reference: 9186098 - Am J Ophthalmol. 1997 Jan;123(1):62-9
– reference: 12654370 - Am J Ophthalmol. 2003 Apr;135(4):521-9
– reference: 15161846 - Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1823-9
– reference: 14985299 - Invest Ophthalmol Vis Sci. 2004 Mar;45(3):840-5
– reference: 10926978 - Am J Ophthalmol. 2000 Jun;129(6):715-22
– reference: 12583788 - Arch Ophthalmol. 2003 Feb;121(2):218-24
– reference: 12689893 - Ophthalmology. 2003 Apr;110(4):719-25
– reference: 7055464 - Arch Ophthalmol. 1982 Jan;100(1):135-46
SSID ssj0004351
Score 1.8407123
Snippet The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 774
SubjectTerms Aged
Area Under Curve
Birefringence
Cornea - physiology
Diagnostic Techniques, Ophthalmological
False Negative Reactions
Glaucoma - diagnosis
Humans
Intraocular Pressure
Lasers
Middle Aged
Ophthalmology
Optic Nerve Diseases - diagnosis
Predictive Value of Tests
ROC Curve
Sensitivity and Specificity
Vision Disorders - diagnosis
Visual Field Tests
Visual Fields
Title Scanning laser polarimetry with variable corneal compensation and detection of glaucomatous optic neuropathy
URI https://www.ncbi.nlm.nih.gov/pubmed/15756574
https://www.proquest.com/docview/230798247
https://www.proquest.com/docview/68534948
Volume 243
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA4-QLyIb9dnDp6EYNu0TXuSXXERwUV8wN5KmkxA0O66WwX_vTNpdxcPemkpTVrIJJNvHvmGsXMZ5Dq3ygqpTSLiFBJRyiwQRkmQ0sUqMeTvuB-kty_x3TAZtrk50zatcqYTvaK2I0M-8ktKWM6zKFZX4w9BRaMouNpW0Fhmq8RcRhldaqgWxyKlr75IDGACJ-5wFtQMGg5RVM-etA8htgh_b0t_YE2_5_Q32UYLFnm3ke4WW4Jqm63dt-HwHfb2ZJqSQxwxMEz4mOzU13eoJ9-cHKz8Cx_pbBRHG7NCSMgpgxwNVy8OrivLLdQ-GaviI8cRSn9iCyqTPuUjVCaGe75LKlv8vcte-jfP17eiLZ8gDGKyWjiXWomAInSJkarMI-VCkC7NAnBgS6cj0IkF79NQZWICBS53eRhFiAKl1nKPrVSjCg4Y9-G8MDOhUxAbVWLr1IRWg9V5ZLOww4LZ6BWm5RanEhdvxZwV2Q94gVeyObICu1zMu4wbYo3_Gh_NRFK0a2xazGdEh53N3-LioIiHrgBHqkgRjBD_TYftN3Jc_Aphapqo-PDfLx-xdU_V6hP-jtlKPfmEEwQhdXnqp9opW-32e70B3ns3g4fHH1m13hY
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEBRol1LqA1yQLJI4iZMDqvrU9rErBK20t-DYY6lSyS67KWh_VP9jx06yVQ_trZdIUWxHGo8933jG3wB8FkGuciMNF0onPE4x4aXIAq6lQCFsLBPtzjuGo3RwEZ-Mk_EK3HR3YVxaZbcn-o3aTLQ7I__mEpbzLIrlzvQvd0WjXHC1q6DRaMUpLv6Txzb_fnxA0_slio4Oz_cHvC0qwDUhlZpbmxpBZja0iRayzCNpQxQ2zQK0aEqrIlSJQe_pyzLRgUSb2zyMIsJGQilB4z6D1ViQJ9OD1b3D0Y-fdxcxha_36DjHOC2VcRdGDRrWUjIIniaQQD0P7xvCB9Ctt3JHr-FVC0_ZbqNPb2AFqzV4PmwD8G_h6pduihwxQt04Y1PnGV_-wXq2YO5Il_2jV3cbi5FXWxEIZS5nnVxlrwBMVYYZrH36V8UmlhF4v6YWrjD7nE1o-9LMM2y6QsmLd3DxJLJ9D71qUuEGMB9ADDMdWomxliW1TnVoFBqVRyYL-xB00it0y2buimpcFUseZi_wgp7Oy8kK6vJ12WXaUHk81nizm5KiXdXzYqmDfdhefqXl6GIsqkKSVJES_HGMO31Yb-bx7lcEjNNExh8eHXkbXgzOh2fF2fHodBNeeqJYn274EXr17Bq3CALV5adW8Rj8fmpdvwXkqho2
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIlVcEN8sBeoDXJCsJnEcJweEEGXVUlohQaW9BcceS5VKdtlNQfvT-HfMOMlWHOitl0hRbEcaz9hvPOM3AK9UUtnKGy-VdVrmBWrZqDKRzihUKuRGOz7vODktDs_yTzM924I_410YTqsc18S4UPu54zPyfU5YrsosN_thyIr4cjB9t_gpuYAUB1rHahq9hhzj-jd5b6u3Rwc01a-zbPrx24dDORQYkI5QSydDKLyiLTcN2inTVJkJKapQlAkG9E2wGVrtMXr9ptEuMRiqUKVZRjhJWato3Ftw2yidsomZmbm6kqli5UdmH5NkNLMxoJr0_KW0NUTCQIL3Mv13S_wPzo373fQe3B2Aqnjfa9Z92ML2AeycDKH4h3Dx1fXljgThb1yKBfvI5z-wW64FH-6KX_TK97IE-bctwVHB2evkNEdVELb1wmMXE8FaMQ-CYPwlteAS7Ssxp4XMici1ySWT14_g7EYk-xi223mLT0HEUGJaujQYzJ1pqHXhUm_R2yrzZTqBZJRe7QZecy6vcVFvGJmjwGt6sr9T1tTlzabLoif1uK7x7jgl9WDfq3qjjRPY23wlw-Roi22RJFUXBISYe2cCT_p5vPoVQeRCm_zZtSPvwQ5peP356PR4F-5ExtiYd_gctrvlJb4gLNQ1L6PWCfh-02r-F_FvHQY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Scanning+laser+polarimetry+with+variable+corneal+compensation+and+detection+of+glaucomatous+optic+neuropathy&rft.jtitle=Graefe%27s+archive+for+clinical+and+experimental+ophthalmology&rft.au=Da+Pozzo%2C+Stefano&rft.au=Iacono%2C+Pierluigi&rft.au=Marchesan%2C+Roberta&rft.au=Fantin%2C+Anna&rft.date=2005-08-01&rft.issn=0721-832X&rft.eissn=1435-702X&rft.volume=243&rft.issue=8&rft.spage=774&rft.epage=779&rft_id=info:doi/10.1007%2Fs00417-004-1118-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00417_004_1118_1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0721-832X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0721-832X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0721-832X&client=summon